Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05855382Completed

Prevalence of Persistent COVID-19 in Punta Arenas, Magallanes and Chilean Antarctic Region

Role: lead

NCT07367867Completed

Inflammation in HIV/AIDS-InflammAIDS

Role: lead

NCT05932797Not ApplicableUnknown

Multimodal Long Covid19

Role: lead

NCT05598892Not ApplicableCompleted

Hand Rehabilitation Based on a RobHand Exoskeleton in Stroke Patients: a Case Series Study

Role: collaborator

All 4 trials loaded